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Bordetella parapertussis is a human pathogen that causes whooping cough. The increasing incidence of B. parapertussis has
been attributed to the lack of cross protection induced by pertussis vaccines. It was previously shown that B. parapertussis is able
to avoid bacterial killing by polymorphonuclear leukocytes (PMN) if specific opsonic antibodies are not present at the site of
interaction. Here, we evaluated the outcome of B. parapertussis innate interaction with humanmacrophages, a less aggressive
type of cell and a known reservoir of many persistent pathogens. The results showed that in the absence of opsonins, O antigen
allows B. parapertussis to inhibit phagolysosomal fusion and to remain alive inside macrophages. The O antigen targets B.
parapertussis to lipid rafts that are retained in the membrane of phagosomes that do not undergo lysosomal maturation. Forty-
eight hours after infection, wild-type B. parapertussis bacteria but not the O antigen-deficient mutants were found colocalizing
with lipid rafts and alive in nonacidic compartments. Taken together, our data suggest that in the absence of opsonic antibodies,
B. parapertussis survives inside macrophages by preventing phagolysosomal maturation in a lipid raft- and O antigen-depen-
dent manner. Two days after infection, about 15% of macrophages were found loaded with live bacteria inside flotillin-enriched
phagosomes that had access to nutrients provided by the host cell recycling pathway, suggesting the development of an intracel-
lular infection. IgG opsonization drastically changed this interaction, inducing efficient bacterial killing. These results highlight
the need for B. parapertussis opsonic antibodies to induce bacterial clearance and prevent the eventual establishment of cellular
reservoirs of this pathogen.
Bordetella parapertussis and Bordetella pertussis are humanpathogens that cause whooping cough, a reemerging disease
that remains a threat to human health. Despite high vaccination
coverage, whooping cough is still endemic. Current clinical sur-
veys indicate that B. parapertussis is responsible for a significant
number of cases of whooping cough, particularly in vaccinated
populations (1–5). The switch from whole-cell to acellular vac-
cines is associatedwith a significant increase in the prevalence ofB.
parapertussis in the epidemiology of the disease (6, 7). Several
studies have demonstrated that pertussis acellular vaccines fail to
protect against B. parapertussis (6, 8). The lack of cross protection
was mainly attributed to the presence of the O antigen on the
surface of B. parapertussis, which blocks antibody access to the
vaccine antigens common to both species (9, 10). In vitro studies
confirmed that pertussis acellular vaccines induce antibodies that
opsonizeB. pertussis but notB. parapertussis (9, 10). In the absence
of opsonic antibodies, B. parapertussis survives neutrophil phago-
cytosis by preventing lysosomal maturation in a lipid raft-depen-
dent manner (11). O antigen is involved in this nonbactericidal
interaction, mediating the targeting of host cell lipid rafts. Several
intracellular pathogens hijack host rafts to create sheltered envi-
ronments that prevent bactericidal activity. In particular, persis-
tent bacteria, such as Mycobacteria spp., Brucella spp., and Legio-
nella pneumophila, were found to generate phagosomes enriched
in raft components which avoid the degradative pathway, allow-
ing long-term bacterial survival inside the host cell (12–18). The
establishment of an intracellular niche provides a significant sur-
vival advantage to these pathogens.
The ability of B. parapertussis to avoid the bactericidal activity
of polymorphonuclear leukocytes (PMN) in the nonimmune host
is likely to contribute to the infectious process, but PMN are un-
likely cells for the establishment of intracellular infections. Many
facultative intracellular bacteria, B. pertussis among them (19),
survive inside macrophages, immune cells that are less aggressive
and live longer than PMN in the human body. Macrophages have
both a primary role in innate immunity and a role in adaptive
immunity. Their ability to influence the immune response makes
them a central determinant of the course of an infection. Intracel-
lular microbes are poised to affect macrophage functions that can
profoundly influence host immune response (20). In the present
study, we examined the interaction between humanmacrophages
and B. parapertussis in order to investigate whether this pathogen
is also able to survive encountering this other cell type and persist
in a viable state for an extended period of time. We identified a
critical role of the O antigen in B. parapertussis survival against
macrophage phagocytosis and a critical role of the Fc receptor
(FcR) in the promotion of cellular bactericidal activity against B.
parapertussis. We also observed a novel association between flotil-
lin and intracellular B. parapertussis cells at times long after infec-
tion and presumably linked to bacterial intracellular survival.
These findings have important implications for our understand-
ing of how this pathogen avoids immune clearance to persist
within the infected host.
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MATERIALS AND METHODS
Bacterial strains and growth. B. parapertussis strain CN2591 and a pre-
viously described isogenic B. parapertussis mutant strain lacking the O
antigen, CN2591wbm (21, 22), were used in this study. For phagocytosis
experiments, these strains were transformed with plasmid pCW505
(kindly supplied by Alison Weiss, Cincinnati, OH), which induces cyto-
plasmic expression of green fluorescent protein (GFP) without affecting
growth or antigen expression (23). Bacteria were stored at 70°C and
recovered by growth on Bordet-Gengou agar (BGA) plates supplemented
with 15% defibrinated sheep blood (bBGA) at 36°C. Bacteria were subse-
quently plated on bBGA, cultured for 20 h at 36°C, and used in all exper-
iments.
Cells. Peripheral blood mononuclear cells (PBMC) from healthy do-
nors were isolated by Ficoll-Paque (GE Healthcare, Uppsala, Sweden)
gradient centrifugation as previously described (24). The mononuclear
cell layer was washed and suspended in Dulbecco’s modified Eagle’s me-
dium (DMEM) containing 10% inactivated autologous normal human
serum, added to tissue culture plates (2 106 cells/ml), and incubated for
2 h at 37°C in 5% CO2. Nonadherent cells were then removed by gentle
washing (three times with DMEM plus 10% inactivated autologous nor-
mal human serum), and adherent cells were cultured for 6 more days in
DMEM plus 10% inactivated autologous normal human serum, as previ-
ously described (19), prior to infection.
Antibodies. The following antibodies were used: polyclonal rabbit
antibody against human flotillin-1 (Santa Cruz Biotechnology, Santa
Cruz, CA), Cy3-conjugated goat F(ab=)2 fragments of anti-rabbit immu-
noglobulin and fluorescein isothiocyanate (FITC)-conjugated goat
F(ab=)2 fragments of anti-rabbit immunoglobulin (both from Jackson
ImmunoResearch, West Grove, PA), and Cy3-conjugated goat F(ab=)2
fragments of anti-mouse immunoglobulin and FITC-conjugated goat
F(ab=)2 fragments of anti-mouse immunoglobulin (from Southern Bio-
technology). Immunoglobulin G (IgG) fractions from pooled sera of
whooping cough patients with high titers of anti-B. parapertussis antibod-
ies, as measured by enzyme-linked immunosorbent assay (25), were iso-
lated as described previously (26). Polyclonal rabbit anti-B. parapertussis
antiserum was obtained as described elsewhere (27).
Macrophage cholesterol sequestration. Before infection, cholesterol
sequestration was achieved by incubating macrophages with 1, 3.5, or 10
mg/ml of methyl--cyclodextrin (15 min at 37°C) or 8, 17.5, or 35 g/ml
of nystatin (30 min at 37°C) in serum-free DMEM plus 0.2% bovine
serum albumin and 5 g/ml lovastatin (DMEM-BSA-L) (methyl--cy-
clodextrin, nystatin, BSA, and lovastatin were all from Sigma). Cells were
then washed and used immediately. Infection was performed in DMEM-
BSA-L to avoid restoration of membrane cholesterol levels due to de novo
synthesis. No decrease in macrophage viability was detected after treat-
ment.
Macrophage treatment with vacuolar-pH-neutralizing reagent.
Neutralization of vacuolar pHwas performed by incubatingmacrophages
with bafilomycin A1 (BAF) (Sigma), an inhibitor of vacuolar v-ATPase.
One hour before infection, 100 nM BAF was added to adherent differen-
tiated macrophages. BAF was maintained during the assay. In control
experiments, the effect of BAF on phagosomal pH was investigated by
incubating B. parapertussis-infectedmacrophages treated with or without
BAFwith LysoTracker redDND-99 (Molecular Probes).NoLysoTracker-
positive organelles were observed in BAF-treated macrophages, as as-
sessed by confocal microscopy. There was no toxic effect of BAF on B.
parapertussis or macrophages, as determined by CFU counts and trypan
blue dye exclusion, respectively.
Quantification of B. parapertussis attachment and phagocytosis.
Bacterial attachment to and phagocytosis by macrophages were evaluated
by double staining and fluorescence microscopy. Macrophages were in-
fected with opsonized or nonopsonized GFP-expressing B. parapertussis
bacteria suspended in DMEMplus 0.2%BSA at amultiplicity of infection
(MOI) of 30 bacteria per cell. The bacterial inoculum was quantified by
CFU counts. To facilitate bacterial interaction with macrophages, plates
were centrifuged for 5 min at 640 g. After 40 min of incubation at 37°C
with 5%CO2, nonadherent bacteria were removed by three washing steps
prior to fixation with 4% paraformaldehyde for 10 min. After fixation,
macrophages were washed once with phosphate-buffered saline (PBS)
and incubated for 10 min at room temperature with PBS containing 50
mMNH4Cl. Macrophage surface-bound and phagocytosed bacteria were
discriminated by using a two-step labeling procedure and fluorescence
microscopy. For this purpose, surface-bound bacteria were evidenced by
incubation with polyclonal rabbit anti-B. parapertussis antiserum (30min
at 4°C), followed by incubation with Cy3-conjugated goat F(ab=)2 frag-
ments of anti-rabbit immunoglobulin (30 min at 4°C). In order to deter-
mine the number of intracellular bacteria, after two washing steps, the
cells were permeabilized by incubationwith PBS containing 0.1% saponin
(Sigma) and 0.2%BSA (30min at 25°C) and further incubatedwith rabbit
anti-B. parapertussis antiserum in the presence of 0.1% saponin and 0.2%
BSA (30 min at 25°C). After washing three times, the macrophages were
incubated with FITC-conjugated F(ab=)2 fragments of goat anti-rabbit
immunoglobulin (30 min at 25°C). Labeling of the bacteria with FITC-
conjugated antibodies was performed to minimize the loss of read-out
sensitivity due to the quenching of GFP fluorescence after internalization.
After washing with distillated water, coverslips were mounted on micro-
scope slides and analyzed by fluorescence microscopy using a DMLB mi-
croscope coupled to a DC100 camera (Leica Microscopy Systems Ltd.,
Heerbrugg, Switzerland). The numbers of extracellular (red and green)
and intracellular (green) bacteria were evaluated by examination of at
least 100 macrophages. All experiments were carried out at least three
times in triplicate.
Confocal microscopy analysis. Colocalization studies were per-
formed as described before (19), with minor modifications. Briefly, mac-
rophages incubated with GFP-expressing B. parapertussis at 37°C for 40
min were washed to remove nonattached bacteria and further incubated
with 100 g/ml polymyxin B for 1 h at 37°C to kill extracellular non-
phagocytosed bacteria. Next, the concentration of polymyxin B was re-
duced to 5 g/ml. At 2 and 48 h postinfection, macrophage samples were
incubated with or without 200 nM LysoTracker DND-99 (5 min at 37°C)
prior to fixation with paraformaldehyde. Those samples that were incu-
bated with LysoTracker stain were washed twice with phosphate-buffered
saline (PBS) and incubated for 10 min at room temperature with PBS
containing 50 mM NH4Cl. After two washing steps, the cells were incu-
bated for 30 min with PBS containing 0.1% saponin and 0.2% BSA, fol-
lowed by incubation with polyclonal rabbit anti-B. parapertussis antise-
rum (30 min at 25°C) in the presence of 0.1% saponin and 0.2% BSA.
After three washing steps, macrophages were incubated with FITC-con-
jugated goat F(ab=)2 fragments of anti-rabbit immunoglobulin (30min at
25°C). Samples of infected cells that were not incubated with LysoTracker
stain were washed twice with PBS and incubated for 10 min at room
temperaturewith PBS containing 50mMNH4Cl. After twowashing steps,
the cells were incubated for 30minwith PBS containing 0.1% saponin and
0.2% BSA. Next, the cells were incubated with rabbit anti-human flotillin
polyclonal antibodies plus polyclonal mouse anti-B. parapertussis antise-
rum (30min at 4°C) in the presence of 0.1% saponin and 0.2%BSA. After
three washing steps, macrophages were incubated with Cy3-conjugated
F(ab=)2 fragments of goat anti-rabbit antibodies plus FITC-conjugated
goat F(ab=)2 fragments of anti-mouse immunoglobulin for another 30
min at 4°C. To avoid cytophilic binding of antibodies to FcR, all incu-
bations were done in the presence of 25% heat-inactivated human serum.
Additionally, isotype controls were run in parallel. Microscopic analyses
were performed using a confocal laser scanning microscope (Leica TCS
SP5; Leica, Germany). The percentage of phagosomes containing bacteria
that colocalizedwith a givenmarkerwas calculated by analyzing at least 50
phagosomes per sample.
Killing assay. Macrophages were infected with B. parapertussis at an
MOI of 30 as described above. The bacterial inoculum was quantified by
plating appropriate dilutions on bBGA. After 40 min of incubation at
37°C with 5% CO2, nonadherent bacteria were removed through three
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washing steps. Then, 100 g/ml polymyxin B sulfate (Sigma) was added
for 1 h to kill the extracellular bacteria. Thereafter, the antibiotic concen-
tration was decreased to 5g/ml. Control experiments showed that in the
presence of 5 g/ml polymyxin B, B. parapertussis bacteria were neither
able to replicate nor to remain alive in the culture medium. The numbers
of CFU in the cell culture supernatants were examined, and no viable
bacteria were detected at any time postinfection.
The macrophages were washed, and intracellular survival of B. parap-
ertussiswas determined at 2 and 48 h postinfection as follows. After wash-
ing with PBS, monolayers were incubated for 15 min at 37°C with PBS
containing 5 mM EDTA and 4 mg/ml lidocaine to promote macrophage
detachment, and cells were scraped immediately. The number of viable
eukaryotic cells was determined by trypan blue dye exclusion. Next, mac-
rophages were lysedwith 0.1% saponin in sterile water and serial dilutions
were rapidly plated onto bBGA plates to enumerate CFU. Control exper-
iments to determine the numbers of phagocytosed bacteria 40min postin-
fection were run in parallel to be used to calculate the percentages of
phagocytosed bacteria that were still alive 2 and 48 h after phagocytosis.
Bacterial phagocytosis was determined by fluorescence microscopy as
previously described. Control experiments were run in parallel to assess
the efficacy of the bactericidal activity of polymyxin B (100 g/ml).
Briefly, samples of 5 108 bacteria were incubated with the antibiotic for
1 h at 37°C and plated on bBGA. This resulted in a 99.999%decrease in the
CFU. No significant differences in bacterial sensitivity to the antibiotics
were detected among the strains used in this study.
In selected experiments, GFP-expressing B. parapertussis was op-
sonized with human IgG (200 g/ml) for 30 min at 37°C prior to incuba-
tion with macrophages.
Fluorescent in situ hybridization staining of intracellular live bac-
teria. Infected macrophages were fixed with 4% paraformaldehyde. Hy-
bridization with fluorescently labeled oligonucleotides was done as de-
scribed previously (28). Alexa Fluor 488-conjugatedDNAprobes BET42a
(5=-GCCTTCCCACTTCGTTT-3=) and EUB338 (5=-GCTGCCTCCCGT
AGGAGT-3=) were designed for rRNA labeling of the betaproteobacteria
and eubacteria, respectively (29). As a negative control, an Alexa Fluor
488-conjugated non-EUB338DNAprobe complementary to EUB338was
used. Bacterial detectability depends on the presence of enough ribosomes
per cell, thus providing information on the viability of the bacteria based
on the amount of ribosomes per cell.
BET42a and EUB338 were used together to get a stronger signal. Both
probes were added to a final concentration of 10 nM in the hybridization
buffer (0.9 M NaCl, 20 mM Tris–HCl, pH 7.4, 0.01% SDS, and 35%
formamide). Next, the hybridization was allowed to occur for 1.5 h at
46°C in a humid chamber. The cells were then washed for 30 min with
buffer (80 mM NaCl, 20 mM Tris–HCl, pH 7.4, 0.01% SDS, and 5 mM
EDTA, pH 8) at 48°C. The total number of intracellular bacteria (both live
and dead) was determined by immune staining using polyclonal mouse
anti-B. parapertussis antiserum followed by Cy3-conjugated F(ab=)2 frag-
ments of goat anti-mouse antibodies as described above. Samples were
mounted onto glass slides. Fluorescent in situ hybridization labeling of
free bacteria incubated with polymyxin B did not give any detectable
signal.
Transferrin uptake. Transferrin uptake by macrophages was assayed
as described before (30), withminormodifications. Briefly, infectedmac-
rophages were depleted of transferrin by incubation inDMEMcontaining
1% BSA for 1 h at 37°C and further incubated for 10 min at 4°C with 10
g/mlAlexa Fluor 594-labeled transferrin (Molecular Probes) in the pres-
ence of BSA (1%) to saturate the capacity for nonspecific endocytosis.
Next, cells were incubated for 5min at 37°C to allow internalization of the
ligand, washed with DMEM containing 1% BSA, and further incubated
for another 45 min at 37°C. Finally, the cells were fixed and microscopic
analyses were performed using a confocal laser scanning microscope
(Leica TCS SP5; Leica, Germany). At least 50 bacteria per sample were
analyzed for colocalization with transferrin in each experiment.
Statistical analysis. Student’s t test (95% confidence level) or analysis
of variance (ANOVA) was used for statistical evaluation of data. The sig-
nificance of the differences between the mean values of the data evaluated
by ANOVA was determined with the least-significant-difference (LSD)
test at a 95% confidence level. Results are shown as means and standard
deviations (SD).
RESULTS
Previous studies have shown that B. parapertussis survives innate
interaction with human PMN (11). Here, we investigated the out-
come of B. parapertussis encounters with macrophages either in
the presence or the absence of opsonic antibodies. IgG-opsonized
or nonopsonized B. parapertussis bacteria were added to adherent
humanmacrophages at anMOI of 30. After 40min of incubation,
the number of macrophage-associated bacteria was determined
by fluorescence microscopy. The results in Fig. 1A show that IgG
opsonization significantly increased bacterial association with the
immune cells. In order to quantify bacterial phagocytosis under
each condition, the numbers of intracellular and extracellular bac-
teria were determined by double immunofluorescence staining.
As can be seen from the results in Fig. 1B, in the absence of op-
sonins, around 59% of the macrophage-associated bacteria were
phagocytosed, while under opsonic conditions, this percentage
went up to 80%. These results indicate that IgG opsonization in-
creased both the attachment and phagocytosis of B. parapertussis.
Phagocytosis does not necessarily result in bacterial killing.We
therefore investigated bactericidal activity upon phagocytosis. Af-
ter an initial infection period of 40min, macrophages were exten-
sively washed and split into two samples. One sample was used to
determine the number of phagocytosed bacteria by two-color
staining and fluorescence microscopy. The other sample was fur-
ther incubated with polymyxin B to kill extracellular bacteria and
determine the counts of viable intracellular bacteria at different
time points. The results in Fig. 1C show the percentages of phago-
cytosed bacteria that were still alive 2 and 48 h postinfection under
the different conditions tested. In the absence of opsonic antibod-
ies, a substantial proportion of B. parapertussis bacteria remained
alive within macrophages 48 h after infection. In the presence of
antibodies, bacterial survival decreased significantly within the
first 2 h andwas almost absent by 48 h (99%decrease) (Fig. 1C),
suggesting that the intracellular fate ofB. parapertussis depends on
themacrophage receptor(s) targeted during the initial bacterium-
host cell interaction. The O antigen was previously implicated in
the survival ofB. parapertussisupon interactionwith humanPMN
(11). In order to determine the relevance of O antigen to B. parap-
ertussis survival in its innate interaction with macrophages, we
evaluated the outcome of macrophage interaction with an O an-
tigen-deficient mutant of B. parapertussis. The lack of the O anti-
gen resulted in a significant decrease in bacterial survival imme-
diately after phagocytosis, and no viable bacteria were found 48 h
postinfection (Fig. 1C), suggesting that O antigen plays a critical
role in B. parapertussis intracellular survival within macrophages.
In order to evaluate bacterial distribution within macrophages
and the proportion of infected cells, double staining and fluores-
cence microscopy were used to determine both the number of
intracellular bacteria per cell and the proportion of macrophages
containing intracellular bacteria. Nonopsonized B. parapertussis
bacteria were still visible within macrophages 48 h after infection
(Fig. 2). Moreover, 14.2% of the macrophages contained more
than 10 intracellular bacteria at this time point. Fluorescent in situ
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hybridization for live bacteria revealed that around 78% of the
nonopsonized intracellular bacteria were alive 48 h after infection
(Fig. 2). Conversely, the O antigen-deficient mutant was found
alive intracellularly only at early time points. Importantly, B.
parapertussis intracellular infections did not affect macrophage
viability as assessed by propidium iodide staining of the cells (31).
Since our results revealed an involvement of theO side chain in
bacterial survival upon macrophage phagocytosis, we next inves-
tigated whether the O antigen affects intracellular trafficking to
avoid bactericidalmechanisms, as found before for other bacterial
pathogens (32–34). To this end, bacterial colocalization with the
acidotropic dye LysoTracker was investigated at different time
points postinfection. The results in Fig. 3 show that 2 h after in-
fection, around 65% of bacteria of the nonopsonized wild-type
strain of B. parapertussis were in nonacidic compartments. Bacte-
ria of the B. parapertussis O antigen-deficient mutant strain
showed a significantly (P 	 0.05) higher level of colocalization
with the acidotropic dye by this early time point. By 48 h, the
different intracellular trafficking of these two strains was evi-
denced by the difference in the percentages of bacteria found in
LysoTracker-negative phagosomes. While around 73% of the
wild-type bacteria were found in nonacidic compartments, no O
antigen-deficient B. parapertussis bacteria were found in Lyso-
Tracker-negative compartments, suggesting that the O antigen is
involved in the ability of B. parapertussis to prevent phagolyso-
some maturation. The intracellular fate of B. parapertussis was
modified by bacterial opsonization with specific IgG antibodies.
The images in Fig. 3A show that opsonized bacteria were already
mainly transported to acidic compartments by 2 h postinfection,
indicating that the ability to prevent phagolysosome maturation
was abrogated by targeting the bacteria to Fc receptors.
In order to investigate the importance of the acidification of B.
parapertussis-containing phagosomes in the bactericidal activity
of the macrophages against this pathogen, bafilomycin A1 (BAF),
an inhibitor of vacuolar ATPase that blocks the acidification of the
late endosomal/lysosomal compartments, was used. BAF had no
toxic effect on B. parapertussis, as assessed by CFU counts (data
not show). One hour before infection, the macrophages were
treated with or without BAF. The drug was present during the
whole experimental period. The numbers of viable intracellular
bacteria 2 and 48 h after infection were determined by fluorescent
in situ hybridization of live bacteria. In control experiments, the
inhibition of vacuolar acidification was confirmed at every time
point by the lack of accumulation of the acidotropic dye Lyso-
Tracker in the intracellular compartments (data not shown). The
number of viable intracellular bacteria increased in BAF-treated
macrophages both at early and late time points (3.1- and 6.8-fold
at 2 and 48 h postinfection, respectively), demonstrating that the
phagosome acidification is required formacrophages to efficiently
kill B. parapertussis.
Taken together, our results suggest that B. parapertussis bacte-
ria remain alive inside the macrophages by preventing phagolyso-
somal maturation. In order to further investigate this issue, the
localization of live bacteria inside the macrophages was deter-
mined by fluorescent in situ hybridization staining for viable bac-
teria. Colocalization studies with LysoTracker dye demonstrated
that 48 h after infection, the viable intracellular bacteriawere those
that did not colocalize with the LysoTracker dye (Fig. 4).
Previous studies have demonstrated that B. parapertussisO an-
tigen interaction with cholesterol-rich domains of PMN is critical
to avoid the lysosomal pathway and bacterial killing (11). Since B.
parapertussis O antigen was involved in the nonbactericidal traf-
FIG 1 Bordetella parapertussis phagocytosis by human macrophages and intracellular survival. (A) Wild-type B. parapertussis (Bpp) and IgG-opsonized B.
parapertussis (IgG-Bpp) bacteria were incubated with macrophages (MOI of 30) for 40 min at 37°C. The cells were washed, fixed, and permeabilized, and
extracellular and intracellular bacteriawere quantified by immunofluorescence staining (green fluorescent dye). The numbers ofmacrophage-associated bacteria
were determined by fluorescence microscopy. At least 100 cells were counted per slide. The data represent the means
 SD of the results of three independent
experiments. The number of IgG-opsonized B. parapertussis bacteria associated withmacrophages was significantly different from the number of nonopsonized
B. parapertussis bacteria (*, P 	 0.05). (B) Wild-type B. parapertussis (Bpp) and IgG-opsonized B. parapertussis (IgG-Bpp) bacteria were incubated with
macrophages (MOI of 30) for 40 min at 37°C. The cells were fixed and permeabilized prior to labeling the intracellular bacteria with green fluorescent dye and
the extracellular bacteria with both green and red fluorescent dyes. The numbers of phagocytosed bacteria were determined by fluorescencemicroscopy. At least
100 cells were counted per slide. Phagocytosis was expressed as the percentage of associated bacteria that were internalized. The data represent the means
 SD
of the results of three experiments withmacrophages from different donors. The level of phagocytosis of nonopsonized B. parapertussis bacteria bymacrophages
was significantly different from themacrophage phagocytosis of IgG-opsonized B. parapertussis bacteria (*, P	 0.05). (C) Nonopsonized B. parapertussis (Bpp),
nonopsonized B. parapertussis O antigen-deficient mutant (Bppwbm), or IgG-opsonized B. parapertussis (IgG-Bpp) bacteria were incubated with human
macrophages (MOI of 30) for 40min at 37°C, washed extensively, and further incubated with polymyxin B to kill the extracellular bacteria. The numbers of CFU
of B. parapertussis per cell were determined at 2 and 48 h postinfection. Bacterial survival was expressed as the percentages of intracellular bacteria at 40 min
postinfection that were still alive 2 and 48 h after phagocytosis. The data represent themeans
 SD of the results of three independent experiments. The numbers
of viable intracellular nonopsonized B. parapertussis bacteria per cell at 2 and 48 h postphagocytosis were significantly different from the numbers of viable
intracellular opsonized B. parapertussis and O antigen-deficient B. parapertussis mutant bacteria at the respective time points (P	 0.05).
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ficking inside macrophages, we next investigated the role of cho-
lesterol-rich domains in the innate interaction of B. parapertussis
with these immune cells. To this end, before bacterial infection,
macrophages were treated with methyl--cyclodextrin, a com-
pound that disrupts cholesterol-rich domains by removing cho-
lesterol from the plasma membrane, and lovastatin, a pharmaco-
logical inhibitor of cholesterol synthesis. The nonopsonized wild
type and an O antigen-deficient mutant of B. parapertussis were
used to infect treated and untreatedmacrophages at anMOI of 30.
After 40 min of infection, the cells were washed and the numbers
of intracellular and extracellular bacteria were determined by
double immunofluorescence staining. Depletion of plasmamem-
brane cholesterol led to a significant (P 	 0.05) decrease in the
phagocytosis level of the nonopsonized B. parapertussis (Fig. 5).
Conversely, phagocytosis of nonopsonized B. parapertussis lack-
ing the expression of the O antigen was not changed significantly
by cholesterol depletion of the immune cells. Together, these data
indicate that theO antigen is involved inB. parapertussisuptake by
macrophages via a mechanism involving cholesterol-rich do-
mains. Despite its different mode of action, similar results were
obtained with nystatin, another lipid raft-disrupting drug that
binds cholesterol (data not shown). Importantly, none of these
molecules had cytotoxic effects onmacrophages, as demonstrated
by propidium iodide staining of the cells (data not show). The
ability of cholesterol-depleted macrophages to phagocytose op-
sonized B. parapertussis was analyzed in parallel. Opsonization
was previously found to direct B. parapertussis through lipid raft-
independent pathways in PMN. The results in Fig. 5 show that the
cholesterol-depleting drug had no effect on bacterial uptake by
macrophages whenB. parapertussiswas opsonized, indicating that
lipid rafts are not involved in macrophage phagocytosis of anti-
body-opsonized bacteria and that macrophage phagocytosis of B.
parapertussis through docking sites other than lipid rafts was not
affected by cholesterol depletion.
To further investigate the involvement of the O antigen in di-
rectingB. parapertussis bacteria tomacrophage lipid rafts, we used
a lipid raft marker, flotillin, and confocal microscopy. Whereas in
uninfected macrophages, flotillin could be seen distributed be-
tween the plasmamembrane and the intracellular stores, infection
of macrophages with the wild type but not with the O antigen-
deficient mutant of B. parapertussis resulted in the relocation and
accumulation of flotillin around the bacteria (Fig. 6). As can be
seen from the results in Fig. 6, at 2 h postinfection, around 60% of
the wild-type bacteria but not of the O antigen-deficient B. parap-
ertussis mutants were found colocalizing with flotillin-enriched
areas. Importantly, this percentage did not vary significantly 48 h
postinfection, indicating that B. parapertussis not only hijacked
host lipid rafts but also retained them in the phagosome mem-
brane inside the cell over time, which might be important in the
intracellular fate of these bacteria.
Since our results suggested that B. parapertussis can avoid bac-
tericidal intracellular trafficking and remain alive inside the host
cell, we next investigated whether B. parapertussis-containing
phagosomes have access to essential nutrients, a prerequisite for
prolonged intracellular survival. To that end, at 48 h postinfec-
tion, macrophages were pulsed with Alexa Fluor 594-transferrin
to assess the access of B. parapertussis-containing phagosomes to
extracellular nutrients. The image in Fig. 7A shows that B. parap-
ertussis O antigen-deficient mutants do not colocalize with Alexa
Fluor 594-transferrin. At this time postinfection, only a fewO-an-
tigen-deficientmutant bacteria were still seen insidemacrophages
and none of them were found colocalizing with transferrin. Con-
versely, the image in Fig. 7B clearly shows colocalization of wild-
type B. parapertussiswith exogenous tranferrin at 48 h after infec-
tion, suggesting that intracellular bacteria have access to essential
nutrients, as expected for a pathogen with long-term intracellular
persistence.
DISCUSSION
Many persistent pathogens that have historically been considered
extracellular, such as Staphylococcus aureus, Helicobacter pylori,
Campylobacter jejuni, and group A streptococci, among others,
were found to have one or more intracellular phases of different
characteristics that play a role in the induction of disease, immune
evasion, and persistence (35–38). Some of them were found to be
able to duplicate within host cells, establishing significant intra-
cellular infections, while others, like Campylobacter jejuni, may
not duplicate inside the cells but still critically depend on their
intracellular phases to establish persistent infections. B. paraper-
FIG 2 Distribution of intracellular live and dead B. parapertussis bacteria at
different times during infection. (A) Nonopsonized B. parapertussis (Bpp) and
nonopsonized B. parapertussisO antigen-deficient mutant (Bppwbm) bacte-
ria were incubated with humanmacrophages (MOI of 30) for 40 min at 37°C,
washed extensively, and further incubated with polymyxin B to kill the extra-
cellular bacteria. After fixation, the numbers of live and dead B. parapertussis
bacteria per cell were determined at 2 and 48 h postinfection by fluorescent in
situ hybridization for live bacteria and immune staining for live and dead
bacteria. The intracellular bacteria were quantified by confocal fluorescence
microscopy. At least 100 cells were counted per slide. The data represent the
means 
 SD of the results of three experiments with macrophages from dif-
ferent donors. The percentages of live intracellular bacteria are indicated in the
bars. (B) Representative confocal microscopy images of macrophages 48 h
postinfection. Live intracellular bacteria are seen in panel a, and both live and
dead bacteria are seen in panel b. Representative confocal microscopy images
from one out of three independent experiments are shown.
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tussis, as well as B. pertussis, were generally considered extracellu-
lar bacteria. Both species are strictly human and persistent patho-
gens that could not be eradicated despite decades of vaccination.
Recent studies support the hypothesis that B. pertussis is indeed a
facultative intracellular bacterium (19). Early studies have sug-
gested that B. parapertussis might also hide inside host cells (11,
39), eventually establishing asymptomatic infections. Clinical
data have also challenged the assumption that B. parapertussis is
strictly extracellular. The source of infection in isolated cases in
which there is no obvious contact with symptomatic individuals
raised questions about how B. parapertussis persists within the
population. Reported cases of bacteremia and death (40–42)
caused by B. parapertussis both in immunocompromised and im-
munocompetent human hosts also argue against a purely extra-
cellular behavior. Also pointing in this direction, recent studies
have shown the importance of adaptive immunity to restrain B.
parapertussis to the lung lumen and the role of the O antigen in B.
parapertussis invasive behavior in the mouse model (43).
Current whooping cough vaccines do not induce antibodies
against B. parapertussis (6, 8, 9, 44, 45). The lipopolysaccharide
(LPS) O antigen was found to be implicated in the lack of protec-
tion of pertussis vaccines against this pathogen by interfering with
the binding of antibodies induced by vaccine antigens common to
both species (9, 10). The O antigen is a key molecule in B. parap-
ertussishost defense evasion. It not only precludes opsonization by
antibodies induced by pertussis vaccines (9) but is also involved in
the nonbactericidal interaction of B. parapertussis with PMN. In
the absence of opsonic antibodies, B. parapertussis survives the
encounter with neutrophils by impairing both cell activation and
phagolysosomal maturation, which eventually leads to bacterial
survival (11). PMN constitute the first line of host defense against
bacterial infections. Bacteria that avoid this defensive barrier can
still be cleared by other host defense cells, such as macrophages.
Macrophages, which exhibit a different set of bactericidal mecha-
nisms than PMN, are also key factors of the innate immune re-
sponse against invading microorganisms. Several pathogens,
however, have evolved strategies to subvert the bactericidal activ-
ity of the macrophages, establishing persistent intracellular infec-
FIG 3 Time course of B. parapertussis colocalization with the acidotropic dye LysoTracker. Nonopsonized B. parapertussis (Bpp), nonopsonized B. parapertussis
Oantigen-deficientmutant (Bppwbm), or IgG-opsonizedB. parapertussis (IgG-Bpp) bacteria were incubatedwith humanmacrophages (MOI of 30) for 40min
at 37°C. After washing, cells were incubated with polymyxin B to kill the extracellular bacteria. Samples were taken at 2 and 48 h postinfection, incubated with
LysoTracker, and fixed. Intracellular bacteria were green fluorescently labeled prior to confocal microscopic analysis. (A) Confocal microscopy images of
macrophages at 2 and 48 h postinfection. Colocalization is reflected by the yellow areas. Representative images from one out of three independent experiments
are shown. (B) The bars indicate percentages of bacteria that are not colocalized with LysoTracker. The data represent the means 
 SD of the results of three
independent experiments.
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tions (46). Bacteria that remain alive in these types of long-lived
cells might hide from the host antimicrobial defense system, reach
other areas or other hosts, or even repopulate the extracellular
medium once the environmental conditions are favorable. More-
over, they might manipulate the host immune response.
We investigated whether B. parapertussis is able to survive en-
counters with these kinds of cells. We examined intracellular sur-
vival over time postphagocytosis, bacterial trafficking inside the
cell, and the importance of specific antibodies in the outcome of
this interaction. To this end, we used macrophages differentiated
from primary human blood monocytes, which are reported to be
a good surrogate for human alveolar macrophages (47, 48), cells
that are likely to interact with B. parapertussis at the site of infec-
tion. Although alveolar macrophages do not derive from blood
monocytes in nature, macrophages differentiated from mono-
cytes have a number of characteristics that makes them resemble
these tissue macrophages. Using this experimental setup, we
found that in the absence of specific antibodies, this pathogen is
able to remain alive for days inside human macrophages. Unlike
what was observed in PMN, we found thatmacrophagesmanaged
to kill a high proportion of bacteria right after phagocytosis but a
significant number of internalized bacteria remained viable
within themacrophages. Considering that most of the population
lacks antibodies against this pathogen, this observation becomes
rather significant. In this study, we used a fluorescent probe spe-
cific for viable bacteria to be able to image their intracellular loca-
tion. By means of this experimental setup, we could not only de-
termine that live bacteria were outside the lysosomes long after
infection but also gain insight into the distribution of viable bac-
teria among the macrophages. Although many macrophages had
cleared intracellular B. parapertussis 2 days after infection, around
14.2% of the macrophages showed high numbers of viable intra-
cellular bacteria residing in nonacidic compartments. Since the
extracellular medium was bactericidal, the high numbers of live
bacteria in these macrophages cannot be explained by newly
phagocytosed bacteria. These results might, then, be consistent
with intracellular replication of B. parapertussis. The number of
intracellular viable bacteria might indeed be a balance between en-
try, intracellular growth, bacterial death, and exit fromcells. Bacterial
survival and eventual duplicationwithin a cell rely on the ability both
to avoid the degradative pathway and to obtain nutrients inside the
cell. We found in the work presented here that 48 h postinfection,
B. parapertussis-containing phagosomes acquired exogenously
added transferrin, indicating that B. parapertussis resides in com-
partments with early endosomal characteristics in which it has
FIG 4 Intracellular live B. parapertussis bacteria do not colocalize with the
acidotropic dye LysoTracker. Nonopsonized B. parapertussis bacteria were in-
cubated with human macrophages (MOI of 30) for 40 min at 37°C, washed
extensively, and further incubated with polymyxin B to kill the extracellular
bacteria. Samples were taken at 48 h and further incubated with LysoTracker
(red), fixed, stained for live B. parapertussis bacteria by fluorescent in situ
hybridization (green), and subjected to confocal microscopic analysis. Colo-
calization is reflected by yellow areas. A representative image fromone of three
independent experiments is shown.
FIG 5 Effects of methyl--cyclodextrin and nystatin on macrophage phagocytosis of B. parapertussis. Human macrophages were treated with or without
methyl--cyclodextrin (1, 3.5, or 10 mg/ml) (A) or nystatin (8, 17.5, or 35 mg/ml) (B) prior to incubation with IgG-opsonized B. parapertussis (IgG-Bpp),
nonopsonized B. parapertussis (Bpp), or nonopsonized B. parapertussisO antigen-deficientmutant (Bppwbm) bacteria (MOI of 30) for 40min at 37°C to allow
phagocytosis. The cells were fixed and permeabilized prior to labeling the intracellular bacteria with green fluorescent dye and the extracellular bacteria with both
green and red fluorescent dyes. To assess the number of phagocytosed bacteria, at least 100 cells per slide were counted. Phagocytosis was expressed as the
percentage of associated bacteria that were internalized. The data represent the means
 SD of the results of four experiments with macrophages from different
donors. Phagocytosis of nonopsonized B. parapertussis by methyl--cyclodextrin-treated macrophages was significantly different from phagocytosis by un-
treated macrophages (P	 0.05).
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access to the recycling compartment, eventually getting essential
nutrients.
As observed for otherO antigen-presenting pathogens, the LPS
O antigen of B. parapertussis was found to be involved in this
long-term intracellular survival. B. parapertussis mutants lacking
the expression of this molecule were killed shortly after macro-
phage phagocytosis. Previous studies have shown that the O anti-
gen is involved in directing other bacteria through an endocytic
pathway that avoids phagosomal maturation into lysosomes by
recruiting lipid rafts in the phagosomal membrane (32). In the
present work, we observed that the B. parapertussis bacteria lack-
ing the LPS O chain entered macrophages in a lipid raft-indepen-
dent manner and their phagosomes fused rapidly with lysosomes.
Colocalization studies showed that wild-type bacteria but not the
O antigen-deficientmutants colocalized with the lipid raft marker
flotillin at early timepoints postinfection. Accordingly, the phago-
cytosis levels of the wild-type bacteria but not the O antigen-defi-
cient mutants were drastically reduced by macrophage treatment
with a cholesterol-sequestering drug, methyl--cyclodextrin.
Similar results were obtained with nystatin, another lipid raft-
disrupting drug that binds cholesterol. Importantly, colocaliza-
tion studies further showed that 2 days after infection, B. paraper-
tussis-containing phagosomes were still enriched in lipid rafts,
which might have a role in bacterial survival. Accordingly, the
percentage of intracellular bacteria colocalizing with lipid raft
markers was similar to both the percentage of viable bacteria and
the percentage of bacteria residing in nonacidic compartments 48
h after infection. The nature of the interaction between O antigen
and lipid rafts, which are microdomains enriched in cholesterol,
glycosphingolipids, and glycosylphosphatidylinositol-anchored
molecules, remains to be investigated. Very little of this interac-
tion can be concluded fromour results. Cholesterol itselfmight be
involved since nystatin, a drug that interferes with cholesterol
binding, decreases B. parapertussis attachment to macrophages.
However, O antigen interaction with other molecules embedded
in lipid rafts cannot be excluded. Likewise, a contribution ofGM1,
FIG 6 B. parapertussis colocalization with flotillin. Nonopsonized B. parapertussis (Bpp) or nonopsonized B. parapertussis O antigen-deficient mutant
(Bppwbm) bacteria were incubated with humanmacrophages (MOI of 30) for 40 min at 37°C. After washing, cells were incubated with polymyxin B to kill the
extracellular bacteria. Samples were taken at different time points (2 or 48 h postinfection). Macrophages were fixed and permeabilized prior to incubation with
antibodies against flotillin-1 (red) or bacteria (green). Colocalization of bacteria and flotillin was investigated using confocalmicroscopy. The bars and error bars
show the mean percentages of flotillin-positive phagosomes 
 SD for three independent experiments. Confocal microscopy images of macrophages 48 h
postinfection are shown. Colocalization is reflected by green fluorescent B. parapertussis surrounded by Cy3-labeled flotillin (indicated by arrows). While both
uninfected and B. parapertussis wbm-infected macrophages show a uniform pattern of distribution of flotillin, macrophages infected with nonopsonized B.
parapertussis do not. Representative images from one of three independent experiments are shown.
Gorgojo et al.
5182 iai.asm.org Infection and Immunity
as found for other pathogens (32, 49), or even CR3, which is
known to interact with the filamentous hemagglutinin of B. per-
tussis, cannot be ruled out. Nevertheless, the results obtained with
the O antigen-deficient mutant of B. parapertussis seem to argue
against the latter possibility. Further studies are needed to dissect
this issue.
The data presented here identify macrophages as a possible
niche of persistence of B. parapertussis. Our results show that the
O antigen protects B. parapertussis from immune functions, al-
lowing the bacteria to eventually hide inside the immune cells.
This seems to be related to the ability of the O antigen to generate
a lipid raft-enriched phagosome, which alters its trafficking to the
degradative pathway. The data obtained in this study will have to
be integratedwith further clinical observations before we can con-
clude that B. parapertussis intracellular survival plays a role in
bacterial pathogenicity andwhooping cough epidemiology. How-
ever, the finding that the presence of opsonic antibodies is criti-
cally required to induce cellular bactericidal activity against B.
parapertussis to promote clearance and to avoid the development
of eventual intracellular infections is already of particular impor-
tance, since current pertussis acellular vaccines do not induce
these kinds of antibodies against B. parapertussis and the innate
immunity is not enough to control this pathogen. The need for a
new generation of vaccines that induce immunity against B.
parapertussis should be considered in order to properly control
whooping cough.
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